Second-line treatment of diffuse large B‐cell lymphoma: Evolution of options
Nicole Fabbri, Alberto Mussetti, Anna Sureda
Topics & Concepts
MedicineChemoimmunotherapyRituximabLenalidomideBendamustineOncologyDiffuse large B-cell lymphomaInternal medicineSalvage therapyRefractory (planetary science)LymphomaNivolumabChemotherapyMultiple myelomaImmunotherapyCancerPhysicsAstrobiologyLymphoma Diagnosis and TreatmentCAR-T cell therapy researchCutaneous lymphoproliferative disorders research